# Proteomic Insights into Heroin Use: Links to Neurodegeneration

**Authors:** Mustafa Gani Sürmen, Sadrettin Pence, Saime Sürmen, Yalcin Buyuk, Sibel Kuras, Birsen Elibol, Halime Hanim Pence

PMC · DOI: 10.1007/s12035-026-05757-4 · 2026-02-21

## TL;DR

This study uses proteomic analysis to identify molecular changes in the brains of heroin users, linking these changes to neurodegeneration and impaired brain function.

## Contribution

The study provides novel proteomic insights into heroin use and its impact on specific brain regions, revealing potential mechanisms of neurodegeneration.

## Key findings

- Heroin use was associated with significant differential expression of proteins in the hippocampus, putamen, and caudate nucleus.
- Altered proteins were linked to oxidative stress and processes related to neurodegeneration and impaired synaptic plasticity.
- Protein–protein interaction networks and enrichment analyses revealed consistent patterns of molecular dysfunction across brain regions.

## Abstract

Due to a lack of information related to molecular changes in heroin use, we aimed to examine heroin-dependent alterations in different regions of the post-mortem human brain. Tissues were obtained from males (n = 24 heroin users, n = 24 controls) through the Turkish Forensic Medicine Institute after structured verbal interviews with the relatives of the deceased to gather history of substance use. Following toxicological confirmation of heroin use, the hippocampus, putamen, and caudate nucleus were dissected from the left hemispheres. Proteomic analyses were performed using a high-resolution liquid chromatography-electrospray ionization-tandem mass spectrometry (LC–ESI–MS/MS) system. Label-free quantitative analysis revealed significant differential expression of 87 proteins in the hippocampus, 121 proteins in the putamen, and 80 proteins in the caudate nucleus compared to controls. These differentially expressed proteins (DEPs) were subsequently used to construct protein–protein interaction (PPI) networks using the STRING database, revealing significantly enriched and highly interconnected interaction networks in all three regions. Gene Ontology (GO) enrichment analysis of DEPs consistently identified extracellular exosome, extracellular space, and vesicle as the top three cellular components. Molecular function enrichment further indicated alterations in signaling, binding, and stress-related processes. The expression of TST, RYR2, ACTBL2, and RPS27 decreased, whereas the expression of COL4A2, OGN, PMP2, and MAP2K6 increased in the hippocampus. In the putamen, the most prominent increases were observed in DNM2 and MADD expression. In the caudate nucleus, the expressions of RPS6KA2, TMED10, and NBEA proteins decreased, whereas HPX protein expression increased. Overall, these alterations promote oxidative stress and molecular changes linked to neurodegeneration, which likely contribute to impaired neuronal function and synaptic plasticity.

The online version contains supplementary material available at 10.1007/s12035-026-05757-4.

## Linked entities

- **Proteins:** TST (thiosulfate sulfurtransferase), RYR2 (ryanodine receptor 2), ACTBL2 (actin beta like 2), RPS27 (ribosomal protein S27), COL4A2 (collagen type IV alpha 2 chain), OGN (osteoglycin), PMP2 (peripheral myelin protein 2), MAP2K6 (mitogen-activated protein kinase kinase 6), DNM2 (dynamin 2), MADD (MAP kinase activating death domain), RPS6KA2 (ribosomal protein S6 kinase A2), TMED10 (transmembrane p24 trafficking protein 10), NBEA (neurobeachin), HPX (hemopexin)
- **Chemicals:** heroin (PubChem CID 5462328)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** RTCB (RNA 2',3'-cyclic phosphate and 5'-OH ligase) [NCBI Gene 51493] {aka C22orf28, DJ149A16.6, FAAP, HSPC117, TSLIG5}, HBD (hypophosphatemic bone disease) [NCBI Gene 100187828], CPE (carboxypeptidase E) [NCBI Gene 1363] {aka BDVS, CPH, IDDHH}, TST (thiosulfate sulfurtransferase) [NCBI Gene 7263] {aka RDS}, ANXA1 (annexin A1) [NCBI Gene 301] {aka ANX1, LPC1}, TMED10 (transmembrane p24 trafficking protein 10) [NCBI Gene 10972] {aka P24(DELTA), S31I125, S31III125, TMP21, Tmp-21-I, p23}, OPALIN (oligodendrocytic myelin paranodal and inner loop protein) [NCBI Gene 93377] {aka HTMP10, TMEM10, TMP10}, WFS1 (wolframin ER transmembrane glycoprotein) [NCBI Gene 7466] {aka CTRCT41, WFRS, WFS, WFSL}, MBP (myelin basic protein) [NCBI Gene 4155], SLC44A2 (solute carrier family 44 member 2 (CTL2 blood group)) [NCBI Gene 57153] {aka CTL2, HNA-3, PP1292}, NONO (non-POU domain containing octamer binding) [NCBI Gene 4841] {aka MRXS34, NMT55, NRB54, P54, P54NRB, PPP1R114}, TXNRD1 (thioredoxin reductase 1) [NCBI Gene 7296] {aka GRIM-12, TR, TR1, TRXR1, TXNR, TXNR1}, ORM1 (orosomucoid 1) [NCBI Gene 5004] {aka A1AG1, AGP-A, AGP1, HEL-S-153w, ORM}, MAP2K6 (mitogen-activated protein kinase kinase 6) [NCBI Gene 5608] {aka CRCMSL, MAPKK6, MEK6, MKK6, PRKMK6, SAPKK-3}, CP (ceruloplasmin) [NCBI Gene 1356] {aka AB073614, CP-2}, COX1 (cytochrome c oxidase subunit I) [NCBI Gene 4512] {aka COI, MTCO1}, A2M (alpha-2-macroglobulin) [NCBI Gene 2] {aka A2MD, CPAMD5, FWP007, S863-7}, SCG2 (secretogranin II) [NCBI Gene 7857] {aka CHGC, EM66, SN, SgII}, RPS16 (ribosomal protein S16) [NCBI Gene 6217] {aka S16, uS9}, NECAB2 (N-terminal EF-hand calcium binding protein 2) [NCBI Gene 54550] {aka EFCBP2, stip-2}, ARRB1 (arrestin beta 1) [NCBI Gene 408] {aka ARB1, ARR1}, HAGH (hydroxyacylglutathione hydrolase) [NCBI Gene 3029] {aka GLO2, GLO2D, GLX2, GLXII, HAGH1}, MOG (myelin oligodendrocyte glycoprotein) [NCBI Gene 4340] {aka BTN6, BTNL11, MOGIG2, NRCLP7}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, CALB2 (calbindin 2) [NCBI Gene 794] {aka CAB29, CAL2, CR}, CFB (complement factor B) [NCBI Gene 629] {aka AHUS4, ARMD14, BF, BFD, CFAB, CFBD}, S100A9 (S100 calcium binding protein A9) [NCBI Gene 6280] {aka 60B8AG, CAGB, CFAG, CGLB, L1AG, LIAG}, GSTO1 (glutathione S-transferase omega 1) [NCBI Gene 9446] {aka GSTO 1-1, GSTTLp28, HEL-S-21, P28, SPG-R}, DBI (diazepam binding inhibitor, acyl-CoA binding protein) [NCBI Gene 1622] {aka ACBD1, ACBP, CCK-RP, EP}, SLC4A1 (solute carrier family 4 member 1 (Diego blood group)) [NCBI Gene 6521] {aka AE1, BND3, CD233, CHC, DI, EMPB3}, COL1A2 (collagen type I alpha 2 chain) [NCBI Gene 1278] {aka EDSARTH2, EDSCV, OI4}, GSTM1 (glutathione S-transferase mu 1) [NCBI Gene 2944] {aka GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, STOM (stomatin) [NCBI Gene 2040] {aka BND7, EPB7, EPB72}, PMP2 (peripheral myelin protein 2) [NCBI Gene 5375] {aka CMT1G, FABP8, M-FABP, MP2, P2}, HCAR3 (hydroxycarboxylic acid receptor 3) [NCBI Gene 8843] {aka GPR109B, HCA3, HM74, PUMAG, Puma-g}, PCBP2 (poly(rC) binding protein 2) [NCBI Gene 5094] {aka HNRNPE2, HNRPE2, hnRNP-E2}, DNPH1 (2'-deoxynucleoside 5'-phosphate N-hydrolase 1) [NCBI Gene 10591] {aka C6orf108, RCL, dJ330M21.3}, HBB (hemoglobin subunit beta) [NCBI Gene 3043] {aka CD113t-C, ECYT6, beta-globin}, PPT1 (palmitoyl-protein thioesterase 1) [NCBI Gene 5538] {aka CLN1, INCL, PPT}, COL4A2 (collagen type IV alpha 2 chain) [NCBI Gene 1284] {aka BSVD2, BSVD2A, BSVD2B, ICH, POREN2}, RPL8 (ribosomal protein L8) [NCBI Gene 6132] {aka L8, uL2}, IGHG4 (immunoglobulin heavy constant gamma 4 (G4m marker)) [NCBI Gene 3503], HPCAL1 (hippocalcin like 1) [NCBI Gene 3241] {aka BDR1, HLP2, VILIP-3}, RYR2 (ryanodine receptor 2) [NCBI Gene 6262] {aka ARVC2, ARVD2, RYR-2, RyR, VACRDS, VTSIP}, SH3GL1 (SH3 domain containing GRB2 like 1, endophilin A2) [NCBI Gene 6455] {aka CNSA1, EEN, SH3D2B, SH3P8}, RAB6A (RAB6A, member RAS oncogene family) [NCBI Gene 5870] {aka RAB6}, RPS6KA2 (ribosomal protein S6 kinase A2) [NCBI Gene 6196] {aka HU-2, MAPKAPK1C, RSK, RSK3, S6K-alpha, S6K-alpha2}, PPP2R2C (protein phosphatase 2 regulatory subunit Bgamma) [NCBI Gene 5522] {aka B55-GAMMA, B55gamma, IMYPNO, IMYPNO1, PR52, PR55G}, PSAT1 (phosphoserine aminotransferase 1) [NCBI Gene 29968] {aka EPIP, NLS2, PSA, PSAT, PSATD}, MAG (myelin associated glycoprotein) [NCBI Gene 4099] {aka GMA, S-MAG, SIGLEC-4A, SIGLEC4, SIGLEC4A, SPG75}, RAB18 (RAB18, member RAS oncogene family) [NCBI Gene 22931] {aka RAB18LI1, WARBM3}, NQO1 (NAD(P)H quinone dehydrogenase 1) [NCBI Gene 1728] {aka DHQU, DIA4, DTD, NMOR1, NMORI, QR1}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, NBEA (neurobeachin) [NCBI Gene 26960] {aka BCL8B, LYST2, NEDEGE}, ND4 (NADH dehydrogenase subunit 4) [NCBI Gene 4538] {aka MTND4}, MAPK6 (mitogen-activated protein kinase 6) [NCBI Gene 5597] {aka ERK3, HsT17250, PRKM6, p97MAPK}, MADD (MAP kinase activating death domain) [NCBI Gene 8567] {aka DEEAH, DENN, IG20, NEDDISH, RAB3GEP, RabGEF}, FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, OGN (osteoglycin) [NCBI Gene 4969] {aka OG, OIF, SLRR3A}
- **Diseases:** learning and memory impairments (MESH:D007859), heroin (MESH:D006556), dementias (MESH:D003704), motor vehicle accidents (MESH:D000081084), cardiac pathologies (MESH:D006331), neuronal (MESH:D009410), drug (MESH:D000081015), depression (MESH:D003866), haemorrhage (MESH:D006470), cognitive dysfunction (MESH:D003072), neuropathological disorders (MESH:D009422), heroin overdose (MESH:D062787), brain tumours (MESH:D001932), synaptic (MESH:D012183), memory impairments (MESH:D008569), synaptic dysfunction (MESH:C536122), opioid addiction (MESH:D009293), head trauma (MESH:D006259), hippocampal dysfunction (MESH:D001927), death (MESH:D003643), Parkinson's disease (MESH:D010300), traumatic injury (MESH:D014947), Neurodegeneration (MESH:D019636), inflammatory (MESH:D007249), epilepsy (MESH:D004827), beta-amyloid toxicity (MESH:D017772), vascular (MESH:D057772), toxicity (MESH:D064420), central nervous system disorders (MESH:D002493), neuroinflammatory (MESH:D000090862), schizophrenia (MESH:D012559), AD (MESH:D000544), neuronal loss or dysfunction (MESH:D060825), psychiatric (MESH:D001523), addictive behaviours (MESH:D019966), infection (MESH:D007239), neurotoxic (MESH:D020258), Huntington's disease (MESH:D006816), cancer (MESH:D009369)
- **Chemicals:** peptides (MESH:D010455), codeine (MESH:D003061), lipids (MESH:D008055), iron (MESH:D007501), iodoacetamide (MESH:D007460), GSH (MESH:D005978), GPI (MESH:D017261), ethanol (MESH:D000431), calcium (MESH:D002118), ROS (MESH:D017382), DTT (MESH:D004229), morphine (MESH:D009020), alcohol (MESH:D000438), SDS (MESH:D012967), amphetamines (MESH:D000662), acetic acid (MESH:D019342), cyanide (MESH:D003486), HCl (MESH:D006851), formic acid (MESH:C030544), benzodiazepines (MESH:D001569), oxygen (MESH:D010100), thiosulfate (MESH:D013885), Ca2+ (-), Heroin (MESH:D003932), sulfur (MESH:D013455), sphingomyelin (MESH:D013109), hydrogen sulfide (MESH:D006862), 6-MAM (MESH:C026979), ABC (MESH:C027043), acetonitrile (MESH:C032159), thiol (MESH:D013438), cocaine (MESH:D003042), urea (MESH:D014508), nitrogen (MESH:D009584), heme (MESH:D006418)
- **Species:** Meleagris gallopavo (common turkey, species) [taxon 9103], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12923500/full.md

---
Source: https://tomesphere.com/paper/PMC12923500